An updated meta-analysis of oxidative stress markers in bipolar disorder

Psychiatry Research

Volumn 218, Issue 1-2, 2014, Pages 61-68

  Brown, Nicole C ^a   Andreazza, Ana C ^a   Young, L Trevor ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antioxidant enzymes; Bipolar disorder; Lipid peroxidation; Oxidative stress; Post mortem brain

Indexed keywords

3 NITROTYROSINE; CARBONYL DERIVATIVE; CATALASE; DNA; GLUTATHIONE PEROXIDASE; LIPID; NITRIC OXIDE; PROTEIN CARBONYL; RNA; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; 3-NITROTYROSINE; BIOLOGICAL MARKER; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TYROSINE;

ARTICLE; BIPOLAR DISORDER; DISEASE ASSOCIATION; DNA DAMAGE; EFFECT SIZE; GENETIC DAMAGE; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA DAMAGE; ANALOGS AND DERIVATIVES; BLOOD; META ANALYSIS; METABOLISM; PHYSIOLOGY;

BIOLOGICAL MARKERS; BIPOLAR DISORDER; CATALASE; GLUTATHIONE PEROXIDASE; HUMANS; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TYROSINE;

EID: 84902087370     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.04.005     Document Type: Article

References (49)

1. Abdalla D.S.P., Monteiro H.P., Oliveira J.A.C., Bechara E.J.H. Activities of superoxide-dismutase and glutathione-peroxidase in schizophrenic and manic-depressive patients. Clinical Chemistry 1986, 32:805-807.
2. Aliyazicioglu R., Kural B., Colak M., Karahan S.C., Ayvaz S., Deger O. Treatment with lithium, alone or in combination with olanzapine, relieves oxidative stress but increases atherogenic lipids in bipolar disorder. Tohoku Journal Experimental Medicine 2007, 213:79-87.
3. Andreazza A.C., Cassini C., Rosa A.R., Leite M.C., de Almeida L.M.V., Nardin P., Cunha A.B.N., Cereser K.M., Santin A., Gottfried C., Salvador M., Kapczinski F., Goncalves C.A. Serum S100B and antioxidant enzymes in bipolar patients. Journal of Psychiatric Research 2007, 41:523-529.
4. Andreazza A.C., Frey B.N., Erdtmann B., Salvador M., Rombaldi F., Santin A., Goncalves C.A., Kapczinski F. DNA damage in bipolar disorder. Psychiatry Research 2007, 153:27-32.
5. Andreazza A.C., Kapczinski F., Kauer-Sant[U+05F3]Anna M., Walz J.C., Bond D.J., Goncalves C.A., Young L.T., Yatham L.N. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. Journal of Psychiatry and Neuroscience 2009, 34:263-271.
6. Andreazza A.C., Kauer-Sant[U+05F3]Anna M., Frey B.N., Bond D.J., Kapczinski F., Young L.T., Yatham L.N. Oxidative stress markers in bipolar disorder: a meta-analysis. Journal of Affective Disorders 2008, 111:135-144.
7. Andreazza A.C., Shao L., Wang J.F., Young L.T. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Archives of General Psychiatry 2010, 67:360-368.
8. Andreazza A.C., Wang J.F., Salmasi F., Shao L., Young L.T. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. Journal of Neurochemistry 2013.
9. +-ATPase activity and lipid peroxidation in bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 37:56-61.
10. Benes F.M., Walsh J., Bhattacharyya S., Sheth A., Berretta S. DNA fragmentation decreased in schizophrenia but not bipolar disorder. Archives of General Psychiatry 2003, 60:359-364.
11. Borenstein, M., Hedges, L., Higgins, J. and Rothstein, H., 2005. Comprehensive Meta Analysis, Version 2. Englewood, NJ: Biostat.
12. Buttner N., Bhattacharyya S., Walsh J., Benes F.M. DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophrenia Research 2007, 93:33-41.
13. Che Y., Wang J.F., Shao L., Young T. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. Journal of Psychiatry and Neuroscience 2010, 35:296-302.
14. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. International Journal of Developmental Neuroscience 2011, 29:311-324.
15. Craddock N., Owen M.J. The beginning of the end for the Kraepelinian dichotomy. British Journal of Psychiatry 2005, 186:364-366.
16. Dowlatshahi D., MacQueen G.M., Wang J.F., Reiach J.S., Young L.T. G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. Journal of Neurochemistry 1999, 73:1121-1126.
17. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997, 315:629-634.
18. Frey B.N., Andreazza A.C., Houenou J., Jamain S., Goldstein B.I., Frye M.A., Leboyer M., Berk M., Malhi G.S., Lopez-Jaramillo C., Taylor V.H., Dodd S., Frangou S., Hall G.B., Fernandes B.S., Kauer-Sant[U+05F3]Anna M., Yatham L.N., Kapczinski F., Young L.T. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Australian and New Zealand Journal of Psychiatry 2013, 47(4):321-332. 10.1177/0004867413478217.
19. Frey B.N., Andreazza A.C., Kunz M., Gomes F.A., Quevedo J., Salvador M., Goncalves C.A., Kapczinski F. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:283-285.
20. Fullerton J.M., Tiwari Y., Agahi G., Heath A., Berk M., Mitchell P.B., Schofield P.R. Assessing oxidative pathway genes as risk factors for bipolar disorder. Bipolar Disorders 2010, 12:550-556.
21. Gawryluk J.W., Wang J.F., Andreazza A.C., Shao L., Young L.T. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. International Journal of Neuropsychopharmacology 2011, 14:123-130.
22. Gergerlioglu H.S., Savas H.A., Bulbul F., Selek S., Uz E., Yumru M. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:697-702.
23. Gigante A.D., Andreazza A.C., Lafer B., Yatham L.N., Beasley C.L., Young L.T. Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia. Neuroscience Letters 2011, 505:47-51.
24. Gu X., Sun J., Li S., Wu X., Li L. Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Abeta production. Neurobiology of Aging 2013, 34:1069-1079.
25. Kapczinski F., Dal-Pizzol F., Teixeira A.L., Magalhaes P.V., Kauer-Sant[U+05F3]Anna M., Klamt F., Moreira J.C., de Bittencourt Pasquali M.A., Fries G.R., Quevedo J., Gama C.S., Post R. Peripheral biomarkers and illness activity in bipolar disorder. Journal of Psychiatric Research 2011, 45:156-161.
26. Khairova R., Pawar R., Salvadore G., Juruena M.F., de Sousa R.T., Soeiro-de-Souza M.G., Salvador M., Zarate C.A., Gattaz W.F., Machado-Vieira R. Effects of lithium on oxidative stress parameters in healthy subjects. Molecular Medicine Reports 2012, 5:680-682.
27. Kim H.J., Soh Y., Jang J.H., Lee J.S., Oh Y.J., Surh Y.J. Differential cell death induced by salsolinol with and without copper: possible role of reactive oxygen species. Molecular Pharmacology 2001, 60:440-449.
28. Klug M., Schmidhofer S., Gebhard C., Andreesen R., Rehli M. 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes. Genome Biology 2013, 14:R46.
29. Kuloglu M., Ustundag B., Atmaca M., Canatan H., Tezcan A.E., Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochemistry and Function 2002, 20:171-175.
30. Kunz M., Gama C.S., Andreazza A.C., Salvador M., Cereser K.M., Gomes F.A., Belmonte-de-Abreu P.S., Berk M., Kapczinski F. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:1677-1681.
31. Kuratomi G., Iwamoto K., Bundo M., Kusumi I., Kato N., Iwata N., Ozaki N., Kato T. Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Molecular Psychiatry 2008, 13:429-441.
32. Machado-Vieira R., Andreazza A.C., Viale C.I., Zanatto V., Cereser V., Vargas R.D., Kapczinski F., Portela L.V., Souza D.O., Salvador M., Gentil V. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neuroscience Letters 2007, 421:33-36.
33. Magalhaes P.V., Jansen K., Pinheiro R.T., Colpo G.D., da Motta L.L., Klamt F., da Silva R.A., Kapczinski F. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Internation Journal of Neuropsychopharmacology 2012, 15:1043-1050.
34. Matarese F., Carrillo-de Santa Pau E., Stunnenberg H.G. 5-Hydroxymethylcytosine: a new kid on the epigenetic block?. Molecular Systems Biology 2011, 7:562.
35. Miklowitz D.J., Schneck C.D., Singh M.K., Taylor D.O., George E.L., Cosgrove V.E., Howe M.E., Dickinson L.M., Garber J., Chang K.K.D. Early Intervention for Symptomatic Youth at Risk for Bipolar Disorder: a randomized trial of family-focused therapy. Journal of the American Academy of Child and Adolescent Psychiatry 2013, 52:121-131.
36. Mustak M.S., Hegde M.L., Dinesh A., Britton G.B., Berrocal R., Subba Rao K., Shamasundar N.M., Rao K.S., Sathyanarayana Rao T.S. Evidence of altered DNA integrity in the brain regions of suicidal victims of Bipolar Depression. Indian Journal of Psychiatry 2010, 52:220-228.
37. Ozcan M.E., Gulec M., Ozerol E., Polat R., Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology 2004, 19:89-95.
38. Perry A., Tarrier N., Morriss R., McCarthy E., Limb K. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. British Medical Journal 1999, 318:149-153.
39. Phillips M.L., Kupfer D.J. Bipolar disorder diagnosis: challenges and future directions. Lancet 2013, 381:1663-1671.
40. Raffa M., Barhoumi S., Atig F., Fendri C., Kerkeni A., Mechri A. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 39:371-375.
41. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., Wagh U.V., Debsikdar V.B., Mahadik S.P. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research 2003, 121:109-122.
42. Savas H.A., Gergerlioglu H.S., Armutcu F., Herken H., Yilmaz H.R., Kocoglu E., Selek S., Tutkun H., Zoroglu S.S., Akyol O. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World Journal of Biological Psychiatry 2006, 7:51-55.
43. Savas H.A., Herken H., Yurekli M., Uz E., Tutkun H., Zoroglu S.S., Ozen M.E., Cengiz B., Akyol O. Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology 2002, 45:57-61.
44. Selek S., Savas H.A., Gergerlioglu H.S., Bulbul F., Uz E., Yumru M. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. Journal of Affective Disorders 2008, 107:89-94.
45. Shan X., Tashiro H., Lin C.L. The identification and characterization of oxidized RNAs in Alzheimer[U+05F3]s disease. Journal of Neuroscience 2003, 23:4913-4921.
46. Soeiro-de-Souza M.G., Andreazza A.C., Carvalho A.F., Machado-Vieira R., Young L.T., Moreno R.A. Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. International Journal of Neuropsychopharmacology 2013, 1-8.
47. Versace A., Andreazza A.C., Young L.T., Fournier J.C., Almeida J.R., Stiffler R.S., Lockovich J.C., Aslam H.A., Pollock M.H., Park H., Nimgaonkar V.L., Kupfer D.J., Phillips M.L. Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Molecular Psychiatry 2013.
48. Wang J.F., Shao L., Sun X., Young L.T. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disorders 2009, 11:523-529.
49. Yanik M., Vural H., Tutkun H., Zoroglu S.S., Sava H.A., Herken H., Kocyigit A., Keles H., Akyol O. The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. European Archives of Psychiatry and Clinical Neuroscience 2004, 254:43-47.